Evidence shows benefit of RSV vaccines as Trump officials push restrictions
The article discusses the ongoing debate around the use of respiratory syncytial virus (RSV) vaccines in the United States. Despite emerging evidence confirming the vaccines' effectiveness in reducing hospitalizations, the Trump administration, led by prominent vaccine critic Robert F. Kennedy Jr., has moved to restrict the availability of these shots. The administration now recommends RSV vaccines only for high-risk infants, rather than all newborns, as part of a broader effort to limit one-third of routine childhood vaccinations. The article suggests that this decision is at odds with the positive data on the vaccines' benefits, highlighting the complex and sometimes contentious nature of vaccine policies in the country.
Source: For the complete article, please visit the original source link below.
